Skip to content

Clinical trials

Glucosephosphate Dehydrogenase Deficiency trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glucosephosphate Dehydrogenase Deficiency Country / region: United States Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20121
20132
20182
20193
20201
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
PATH2
University of Mississippi, Oxford2
Allergan1
Baebies, Inc.1
Columbia University1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company1
Pediatrix1
RTI International1
Sanguine Biosciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glucosephosphate Dehydrogenase Deficiency14
Hemolysis3
Anemia, Sickle Cell2
Cystic Fibrosis2
Diabetes Mellitus2
Epilepsy2
Hyperbilirubinemia2
Malaria2
Muscular Atrophy, Spinal2
Muscular Dystrophy, Duchenne2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.